Whitepaper

Patient Engagement Experience – Add a Pinch of Perception, Sustainability, and Analytics to Your Existing Database and See the Difference

The world today is moving towards a proactive than reactive approach. Most pharmaceutical and medical device companies depend on expensive clinical and drug user databases that charge them hefty subscription fees for feeds that are mostly available in the public domain.

Key Takeaways:

  • The convergence of patient experience, perception, and decision-making process should be merged with the offerings and solutions.
  • With data convergence set to play a major role in PEP, wearables, learning, and development, marketing, app-based data, and salesforce data (from drug/product companies) will become integrated.
  • Dependency on fixed metrics on subscription-based databases will also lead to major failures of strategy.

To know more...



Related Topics

ESG Data Report

White Papers

ESG Data Insights Report 2025

ESG is no longer a checkbox—it’s the driving force behind investment decisions. With sustainability at the forefront of financial markets,...

ESG Whitepaper 2024

White Papers

The Green Deception: Is the Promise of Sustainability Real?

Sustainability has rapidly evolved from a niche concern to a crucial pillar of global economic, environmental, and social doctrine. Governments,...

We bring comprehensive data driven insights to everyone, everywhere